A diagnostic kit for lung cancer based on gene methylation in lung tissue
A lung cancer diagnosis and methylation technology, applied in the direction of recombinant DNA technology, biochemical equipment and methods, microbial measurement/testing, etc., to achieve good application value
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] Example 1 Bisulfite sequencing kit for lung cancer diagnosis
[0031] 1. Composition of the kit
[0032] The sample used in the kit is lung tissue DNA, and the reagents include bisulfite reagent, sequencing library building reagent and PCR amplification reagent.
[0033] The bisulfite reagent is a bisulfite reagent commonly used in the field for methylation sequencing, and its function is to convert unmethylated C bases into U, and the reagents are commercially available (for example: EpiTech Reagent). Sulfite Kit (A-59104), Tiangen DNA Bisulfite Conversion Kit (DP215), etc.).
[0034] The sequencing library building reagent is a reagent for performing end repair on DNA and adding sequencing adapters, and is commercially available, such as Ironman library building kit.
[0035]The PCR amplification reagents include primers, commercially available PCR master mixes for amplifying DNA segments of interest (CYCS, LOC283585, ZNF316 genes, THEG5, MIR1233-1 and LOC102724050)...
Embodiment 2
[0044] Embodiment 2 The methylation status of the aforementioned 6 genes is correlated with lung cancer
[0045] 1. Clinical samples
[0046] Patients with pulmonary nodules who were to undergo surgical resection were consecutively included, and the inclusion criteria were as follows: (1) pulmonary nodules were present on chest CT; (2) surgical resection was performed at the Department of Thoracic Surgery, West China Hospital, Sichuan University and confirmed by pathology (with sufficient sample size); (3) No previous history of lung cancer or other tumors; ④ No history of radiotherapy, chemotherapy, etc.; The exclusion criteria were as follows: ① Combined with imaging manifestations such as atelectasis, pneumonia, hilar enlargement or pleural effusion; ② Combined with other serious diseases (severe cardiovascular or pulmonary disease, etc.); a total of 100 cases of pulmonary nodules were included The specific clinical characteristics of the patients are shown in the table be...
PUM
| Property | Measurement | Unit |
|---|---|---|
| Sensitivity | aaaaa | aaaaa |
| Sensitivity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


